Join
Live feed
·
PRReleasevia Quantisnow
Gamida Cell Ltd. logo

Gamida Cell Announces FDA Acceptance of Biologics License Application for Omidubicel with Priority Review

ByQuantisnow·Wall Street's wire, on your screen.
GMDA· Gamida Cell Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GMDA (Gamida Cell Ltd.) and more on Quantisnow.